{"id":35886,"date":"2025-06-10T16:59:19","date_gmt":"2025-06-10T13:59:19","guid":{"rendered":"https:\/\/massivebio.com\/?p=35886"},"modified":"2025-06-10T16:59:19","modified_gmt":"2025-06-10T13:59:19","slug":"non-small-cell-lung-cancer-vs-other-types-key-differences","status":"publish","type":"post","link":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/","title":{"rendered":"Non-Small Cell Lung Cancer vs. Other Types: Key Differences"},"content":{"rendered":"<p class=\"ai-optimize-58 ai-optimize-introduction\"><section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p class=\"ai-optimize-8\"><span style=\"font-weight: 400;\">Lung cancer is one of the most frequently diagnosed cancers globally and a significant cause of cancer-related mortality. Accounting for roughly 85% of lung cancers,<\/span><a href=\"https:\/\/massivebio.com\/non-small-cell-lung-cancer\/\"> <span style=\"font-weight: 400;\">non-small cell lung cancer<\/span><\/a><span style=\"font-weight: 400;\"> (NSCLC) is the most widespread form. Despite its prevalence, NSCLC is often misunderstood, particularly in the context of <\/span><b>small cell lung cancer vs non-small cell lung cancer<\/b><span style=\"font-weight: 400;\">, where key differences in behavior, treatment, and outcomes can significantly impact care decisions.<\/span><\/p>\n<p class=\"ai-optimize-11\"><b>Non-small cell lung cancer <\/b><span style=\"font-weight: 400;\">is a leading type of lung cancer, distinct from small cell lung cancer in how it grows, is treated, and affects prognosis. This guide explains what NSCLC is, how it compares to other forms of lung cancer, and outlines key differences in <\/span><b>non small cell lung cancer causes<\/b><span style=\"font-weight: 400;\">, stages, treatment options, and outlook. Whether you&#8217;re looking for clarity after a recent diagnosis or aiming to understand the broader landscape better, the information ahead provides a clearer picture of this complex condition.<\/span><\/p>\n<h2 class=\"ai-optimize-12\"><span style=\"font-weight: 400;\">What is Non-Small Cell Lung Cancer?<\/span><\/h2>\n<p class=\"ai-optimize-13\"><span style=\"font-weight: 400;\">Non-small cell lung cancer (NSCLC) includes multiple subtypes that vary from small cell lung cancer (SCLC) in how they grow, respond to treatment, and affect outcomes. The primary forms of NSCLC include:\u00a0<\/span><\/p>\n<ul>\n<li class=\"ai-optimize-14\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Adenocarcinoma: This is the most frequently diagnosed type, particularly in individuals who have never smoked. It typically starts in the peripheral regions of the lungs.<\/span><\/li>\n<li class=\"ai-optimize-15\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Squamous Cell Carcinoma: Frequently associated with smoking, this cancer usually forms in the central parts of the lungs close to the bronchial tubes.<\/span><\/li>\n<li class=\"ai-optimize-16\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Large Cell Carcinoma: An uncommon and aggressive lung cancer subtype that may occur in various lung regions.<\/span><\/li>\n<\/ul>\n<p class=\"ai-optimize-17\"><span style=\"font-weight: 400;\">Understanding the differences between <\/span><b>small cell vs non small cell lung cancer<\/b><span style=\"font-weight: 400;\"> is critical because they have distinct behaviors, responses to treatment, and survival rates. While non-small cell lung cancer usually progresses more slowly than small cell lung cancer, early detection is still challenging.\u00a0<\/span><\/p>\n<h2 class=\"ai-optimize-18\"><span style=\"font-weight: 400;\">Causes and Risk Factors: What Triggers NSCLC?<\/span><\/h2>\n<p class=\"ai-optimize-19\"><span style=\"font-weight: 400;\">One of the most pressing questions is, <\/span><b>&#8220;What is non small cell lung cancer?&#8221;<\/b><span style=\"font-weight: 400;\"> While smoking remains the dominant risk factor, NSCLC is increasingly diagnosed in non-smokers as well, pointing to a multifactorial origin. <\/span><span style=\"font-weight: 400;\">Major causes and risk factors include:<\/span><\/p>\n<ul>\n<li class=\"ai-optimize-20\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Tobacco Smoking: The leading cause. However, adenocarcinoma, a common type of NSCLC, is often seen in never-smokers.<\/span><\/li>\n<li class=\"ai-optimize-21\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Secondhand Smoke: Being around tobacco smoke from others notably boosts the chances of lung cancer.<\/span><\/li>\n<li class=\"ai-optimize-22\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Environmental Pollutants: Radon gas, asbestos, and air pollution are all associated with an increased risk of developing non-small cell lung cancer.<\/span><\/li>\n<li class=\"ai-optimize-23\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Genetics: In some cases, family history and inherited genetic mutations can contribute to the development of non-small cell lung cancer.<\/span><\/li>\n<li class=\"ai-optimize-24\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Previous Radiation Therapy: Particularly radiation targeted at the chest area for other cancers, which can increase the risk.<\/span><\/li>\n<\/ul>\n<p class=\"ai-optimize-25\"><span style=\"font-weight: 400;\">Though the causes of non-small cell and small cell lung cancer overlap, their behavior in the body and progression primarily distinguish them.<\/span><\/p>\n<h2 class=\"ai-optimize-26\"><span style=\"font-weight: 400;\">Staging and Spread: How NSCLC Progresses Compared to Other Types<\/span><\/h2>\n<p class=\"ai-optimize-27\"><span style=\"font-weight: 400;\">Understanding<\/span><a href=\"https:\/\/massivebio.com\/small-cell-lung-cancer-symptoms\/\"> <span style=\"font-weight: 400;\">non small cell lung cancer symptoms<\/span><\/a><span style=\"font-weight: 400;\">, staging and is essential for choosing appropriate treatments and estimating outcomes. NSCLC is staged from I to IV:<\/span><\/p>\n<ul>\n<li class=\"ai-optimize-28\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stage I-II: The cancer is localized to the lungs and possibly nearby lymph nodes.<\/span><\/li>\n<li class=\"ai-optimize-29\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stage III: The cancer has extended into surrounding tissues or distant lymph nodes.<\/span><\/li>\n<li class=\"ai-optimize-30\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stage IV: Known as<\/span><b> stage 4 non small cell lung cancer<\/b><span style=\"font-weight: 400;\">, the disease has metastasized to other parts of the body, such as bones, brain, or liver.<\/span><\/li>\n<\/ul>\n<p class=\"ai-optimize-31\"><span style=\"font-weight: 400;\">Small cell lung cancer is usually staged as either limited, affecting one lung and adjacent lymph nodes, or extensive, involving spread beyond one side of the chest, underscoring how rapidly it progresses.<\/span><\/p>\n<h3 class=\"ai-optimize-32\"><span style=\"font-weight: 400;\">Metastatic Non-Small Cell Lung Cancer<\/span><\/h3>\n<p class=\"ai-optimize-33\"><span style=\"font-weight: 400;\">When non-small cell lung cancer reaches stage 4, known as metastatic NSCLC, it has spread beyond the lungs to other organs. Treatment at this point typically relies on systemic approaches, as surgery is no longer feasible.<\/span><\/p>\n<h2 class=\"ai-optimize-34\"><span style=\"font-weight: 400;\">Treatment Options: Non-Small Cell Lung Cancer vs. Other Types<\/span><\/h2>\n<p class=\"ai-optimize-35\"><span style=\"font-weight: 400;\">Treatment plans differ significantly between small and nonsmall cell lung cancer, owing to their biological differences and growth rates. <\/span><span style=\"font-weight: 400;\">Non-small cell lung cancer treatment approaches:<\/span><\/p>\n<ul>\n<li class=\"ai-optimize-36\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Surgery: Often used in early stages to remove tumors.<\/span><\/li>\n<li class=\"ai-optimize-37\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Radiation Therapy: Can be administered independently or together with surgery or chemotherapy.<\/span><\/li>\n<li class=\"ai-optimize-38\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Chemotherapy: Used as a neoadjuvant treatment before surgery, as adjuvant therapy after surgery, or for advanced disease stages.<\/span><\/li>\n<li class=\"ai-optimize-39\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Targeted Therapy: Drugs that target specific mutations like EGFR or ALK are effective in certain patients.<\/span><\/li>\n<li class=\"ai-optimize-40\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Immunotherapy: Immune checkpoint inhibitors have revolutionized treatment for advanced NSCLC, especially in <\/span><b>non small cell lung cancer stage 4<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<p class=\"ai-optimize-41\"><span style=\"font-weight: 400;\">SCLC, on the other hand, is rarely treated with surgery because it tends to spread quickly. Chemotherapy and radiation are commonly used together, while immunotherapy is gaining interest.<\/span><\/p>\n<p class=\"ai-optimize-42\"><span style=\"font-weight: 400;\">Patients with <\/span><b>metastatic non small cell lung cancer<\/b><span style=\"font-weight: 400;\"> may live longer with immunotherapy or targeted therapy than those with extensive-stage SCLC, but each patient&#8217;s outcome varies widely.<\/span><\/p>\n<h2 class=\"ai-optimize-43\"><span style=\"font-weight: 400;\">Prognosis and Outlook: Comparing Survival Rates<\/span><\/h2>\n<p class=\"ai-optimize-44\"><span style=\"font-weight: 400;\">The <\/span><b>non small cell lung cancer prognosis<\/b><span style=\"font-weight: 400;\"> largely depends on the stage at diagnosis, molecular features, and overall health of the patient. While survival rates have improved, late-stage diagnosis still poses significant challenges. Non small cell lung cancer prognosis by stage:<\/span><\/p>\n<ul>\n<li class=\"ai-optimize-45\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stage I: The 5-year survival rate is around 60\u201370%.<\/span><\/li>\n<li class=\"ai-optimize-46\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stage II: Drops to 30\u201350%.<\/span><\/li>\n<li class=\"ai-optimize-47\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stage III: Around 15\u201330%, depending on the extent and treatment response.<\/span><\/li>\n<li class=\"ai-optimize-48\" style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Stage 4 Non-Small Cell Lung Cancer: The 5-year survival rate is approximately 8\u201310%, but new therapies are pushing those numbers up slightly in recent years.<\/span><\/li>\n<\/ul>\n<p class=\"ai-optimize-49\"><span style=\"font-weight: 400;\">Small cell lung cancer generally shows more aggressive behavior than NSCLC and is often discovered at later stages. Survival at five years for extensive-stage cases is usually less than 5%. The disparity in outcomes highlights the importance of early detection, personalized treatment, and emerging research.<\/span><\/p>\n<p class=\"ai-optimize-50\"><span style=\"font-weight: 400;\">The question,<\/span><a href=\"https:\/\/massivebio.com\/what-are-the-differences-between-small-cell-and-non-small-cell-lung-cancer\/\"> <span style=\"font-weight: 400;\">What are the Differences Between Small Cell and Non-Small Cell Lung Cancer?<\/span><\/a><span style=\"font-weight: 400;\">, is fundamental for understanding diagnosis, treatment options, and prognosis. Differentiating non-small cell lung cancer from other forms such as small cell lung cancer plays a crucial role in effective care and treatment planning. From the <\/span><b>types of non small cell lung cancer<\/b><span style=\"font-weight: 400;\"> to its causes, staging, treatment, and prognosis, every element plays a role in determining the path forward. NSCLC tends to be less aggressive than SCLC, yet early detection and effective treatment remain crucial, especially for stage 4 or metastatic disease.\u00a0<\/span><\/p>\n<p class=\"ai-optimize-51\"><span style=\"font-weight: 400;\">If you or a loved one is facing a lung cancer diagnosis, consult a multidisciplinary oncology team to explore the best possible care strategy. With continued research and innovation, the landscape for <\/span><b>non small cell lung cancer treatment<\/b><span style=\"font-weight: 400;\"> is brighter than ever. Discover how Massive Bio is reshaping the future of cancer care\u2014putting patients first and unlocking doors to groundbreaking clinical trials.<\/span><\/p>\n<p class=\"ai-optimize-52\"><a href=\"https:\/\/www.medicalnewstoday.com\/articles\/316477#:~:text=Takeaway-,Small%2Dcell%20lung%20cancer%20(SCLC)%20and%20non%2Dsmall,adults%20in%20the%20United%20States\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.medicalnewstoday.com\/articles\/316477#:~:text=Takeaway-,Small%2Dcell%20lung%20cancer%20(SCLC)%20and%20non%2Dsmall,adults%20in%20the%20United%20States<\/span><\/a><span style=\"font-weight: 400;\">.\u00a0<\/span><\/p>\n<p class=\"ai-optimize-53\"><a href=\"https:\/\/www.nfcr.org\/blog\/small-cell-lung-cancer-vs-non-small-cell-lung-cancer-whats-the-difference\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.nfcr.org\/blog\/small-cell-lung-cancer-vs-non-small-cell-lung-cancer-whats-the-difference\/<\/span><\/a><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-54\"><a href=\"https:\/\/www.webmd.com\/lung-cancer\/small-cell-vs-non-small-cell-lung-cancer\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.webmd.com\/lung-cancer\/small-cell-vs-non-small-cell-lung-cancer<\/span><\/a><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-59\">\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Lung cancer is one of the most frequently diagnosed cancers globally and a significant cause of cancer-related mortality. Accounting for roughly 85% of lung cancers, non-small cell lung cancer (NSCLC) is the most widespread form. Despite its prevalence, NSCLC is often misunderstood, particularly in the context of small cell lung cancer vs non-small cell lung...","protected":false},"author":11,"featured_media":35887,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57],"tags":[],"class_list":["post-35886","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Non-Small Cell Lung Cancer vs. Other Types: Key Differences<\/title>\n<meta name=\"description\" content=\"Lung cancer is one of the most frequently diagnosed cancers globally and a significant cause of cancer-related mortality. Accounting for roughly 85% of lung cancers, non-small cell lung cancer (NSCLC) is the most widespread form.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Non-Small Cell Lung Cancer vs. Other Types: Key Differences %\" \/>\n<meta property=\"og:description\" content=\"Lung cancer is one of the most frequently diagnosed cancers globally and a significant cause of cancer-related mortality. Accounting for roughly 85% of lung cancers, non-small cell lung cancer (NSCLC) is the most widespread form.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-10T13:59:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/Non-Small-Cell-Lung-Cancer-vs.-Other-Types-Key-Differences.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"767\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Non-Small Cell Lung Cancer vs. Other Types: Key Differences","description":"Lung cancer is one of the most frequently diagnosed cancers globally and a significant cause of cancer-related mortality. Accounting for roughly 85% of lung cancers, non-small cell lung cancer (NSCLC) is the most widespread form.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/","og_locale":"en_US","og_type":"article","og_title":"Non-Small Cell Lung Cancer vs. Other Types: Key Differences %","og_description":"Lung cancer is one of the most frequently diagnosed cancers globally and a significant cause of cancer-related mortality. Accounting for roughly 85% of lung cancers, non-small cell lung cancer (NSCLC) is the most widespread form.","og_url":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2025-06-10T13:59:19+00:00","og_image":[{"width":1024,"height":767,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/Non-Small-Cell-Lung-Cancer-vs.-Other-Types-Key-Differences.jpg","type":"image\/jpeg"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Non-Small Cell Lung Cancer vs. Other Types: Key Differences","datePublished":"2025-06-10T13:59:19+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/"},"wordCount":1133,"commentCount":12,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/Non-Small-Cell-Lung-Cancer-vs.-Other-Types-Key-Differences.jpg","articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/","url":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/","name":"Non-Small Cell Lung Cancer vs. Other Types: Key Differences","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/Non-Small-Cell-Lung-Cancer-vs.-Other-Types-Key-Differences.jpg","datePublished":"2025-06-10T13:59:19+00:00","description":"Lung cancer is one of the most frequently diagnosed cancers globally and a significant cause of cancer-related mortality. Accounting for roughly 85% of lung cancers, non-small cell lung cancer (NSCLC) is the most widespread form.","breadcrumb":{"@id":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/Non-Small-Cell-Lung-Cancer-vs.-Other-Types-Key-Differences.jpg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/Non-Small-Cell-Lung-Cancer-vs.-Other-Types-Key-Differences.jpg","width":1024,"height":767,"caption":"Non Small Cell Lung Cancer vs. Other Types Key Differences"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/non-small-cell-lung-cancer-vs-other-types-key-differences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"Blog","item":"https:\/\/massivebio.com\/blog-en\/"},{"@type":"ListItem","position":3,"name":"Non-Small Cell Lung Cancer vs. Other Types: Key Differences"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/35886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=35886"}],"version-history":[{"count":1,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/35886\/revisions"}],"predecessor-version":[{"id":35888,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/35886\/revisions\/35888"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/35887"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=35886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=35886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=35886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}